We are live on ! Find out more
AMIX

Autonomix Medical

12 hedge funds and large institutions have $221K invested in Autonomix Medical in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

149% more capital invested

Capital invested by funds: $88.9K → $221K (+$132K)

33% more funds holding

Funds holding: 912 (+3)

0% more ownership

Funds ownership: 0%0% (+0%)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
12
Holders Change
+3
Holders Change %
+33.33%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
4
Closed
1
Calls
Puts
Net Calls
Net Calls Change

AMIX Hedge Fund Activity: Q3 2024 in Review

12 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Autonomix Medical (AMIX) for Q3 2024, worth a combined $221K — up 149% from $88.9K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new AMIX positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 4 trimmed.

The largest buyer was Mariner, opening a new position worth an estimated $90K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $16K sold.

  • 12 institutional investors held Autonomix Medical (AMIX) as of Q3 2024, up from 9 in Q2 2024.
  • Funds reported $221K of Autonomix Medical stock for Q3 2024, up 149% quarter-over-quarter.
  • 4 funds opened new Autonomix Medical positions in Q3 2024 and 1 closed out, a net change of +3 holders.
  • The largest Autonomix Medical buyer in Q3 2024 was Mariner, an estimated $90K added.
  • The largest Autonomix Medical seller in Q3 2024 was Renaissance Technologies, an estimated $16K sold.

Based on aggregated 13F filings for Q3 2024.